Key Takeaways
- • Multicoin Capital general partner Spencer Applebaum told Bloomberg that Hyperliquid's HYPE token is the largest holding in the firm's hedge fund.
- • Multicoin did not disclose the size or portfolio weighting of its HYPE position.
- • Applebaum said Multicoin bought the position on public markets and typically holds such assets for several years.
- • Coverage reports that Multicoin has rejected an AI pivot, according to the headline.
Summary
Multicoin Capital general partner Spencer Applebaum told Bloomberg that Hyperliquid's HYPE token is the largest holding in the firm's hedge fund. He did not disclose the size of the position or its weighting within the portfolio. According to Applebaum, Multicoin acquired the position on public markets and typically holds assets of this kind for several years.
The disclosure comes alongside reporting that Multicoin has rejected an AI pivot, as indicated by the headline of coverage from Crypto News. The available source material does not provide further detail on the terms or rationale of that decision, and the full text of the Bloomberg interview was not available for this summary.
For allocators, the key points are the concentration signal, since HYPE is the fund's top holding by Applebaum's account, and the stated holding horizon of several years. Without disclosed position sizing, the scale of the exposure relative to fund AUM cannot be assessed.
The disclosure comes alongside reporting that Multicoin has rejected an AI pivot, as indicated by the headline of coverage from Crypto News. The available source material does not provide further detail on the terms or rationale of that decision, and the full text of the Bloomberg interview was not available for this summary.
For allocators, the key points are the concentration signal, since HYPE is the fund's top holding by Applebaum's account, and the stated holding horizon of several years. Without disclosed position sizing, the scale of the exposure relative to fund AUM cannot be assessed.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.